Peripheral T-cell lymphoma, not otherwise specified: a retrospective single-center analysis

  • SUZUKI Takaharu
    Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University
  • KAWAMOTO Keisuke
    Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University Department of Pathophysiology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences
  • TAMURA Suguru
    Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University
  • UEMURA Shun
    Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University
  • KAIHATSU Akane
    Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University
  • NEMOTO Hiroki
    Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University
  • KOBAYASHI Hironori
    Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University
  • USHIKI Takashi
    Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University
  • FUSE Kyoko
    Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University
  • SHIBAZAKI Yasuhiko
    Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University
  • MORIYAMA Masato
    Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University
  • MASUKO Masayoshi
    Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University
  • NARITA Miwako
    Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University
  • SONE Hirohito
    Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University
  • AOKI Sadao
    Department of Pathology, Faculty of Medicine, Tokai University
  • NAKAMURA Naoya
    Department of Pathology, School of Medicine, Kurume University
  • OSHIMA Koichi
    Department of Pathophysiology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences
  • TAKIZAWA Jun
    Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University

Bibliographic Information

Other Title
  • 単一施設における末梢性T細胞リンパ腫,非特定型の後方視的解析
  • 臨床研究 第5回日本血液学会関東甲信越地方会 奨励賞 単一施設における末梢性T細胞リンパ腫,非特定型の後方視的解析
  • リンショウ ケンキュウ ダイ5カイ ニホン ケツエキ ガッカイ カントウ コウシンエツチホウカイ ショウレイショウ タンイツ シセツ ニ オケル マッショウセイ Tサイボウ リンパシュ,ヒトクテイガタ ノ コウホウ シテキ カイセキ

Search this article

Abstract

<p>We retrospectively analyzed clinical and pathological features, treatments, and prognoses in 28 patients with newly diagnosed peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) in Niigata University Medical and Dental Hospital. Of them, 16 were males and 12 were females, and their median age was 62.5 (range, 26-88) years. The International Prognostic Index was high-intermediate/high in 68% of patients. Twelve patients were treated with CHOP/THP-COP and nine with third-generation chemotherapy regimens. At a median follow-up period of 30 (range: 1-164) months, the 2-year overall survival and progression-free survival rates were 61% and 44%, respectively. Further investigation of novel agents for treating PTCL-NOS is warranted.</p>

Journal

  • Rinsho Ketsueki

    Rinsho Ketsueki 58 (8), 905-911, 2017

    The Japanese Society of Hematology

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top